• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身间充质干细胞来源的外泌体可减小心肌梗死面积:猪模型的MRI特征分析

Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine Model.

作者信息

Charles Christopher J, Li Renee R, Yeung Teresa, Mazlan Stephane M Ibraham, Lai Ruenn Chai, de Kleijn Dominique P V, Lim Sai Kiang, Richards A Mark

机构信息

Cardiovascular Research Institute (CVRI), National University Heart Centre, Singapore, Singapore.

Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

出版信息

Front Cardiovasc Med. 2020 Nov 16;7:601990. doi: 10.3389/fcvm.2020.601990. eCollection 2020.

DOI:10.3389/fcvm.2020.601990
PMID:33304934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7701257/
Abstract

The observations that mesenchymal stem cells (MSCs) exert cardiac protection and repair via their secretome with the active component(s) identified as exosomes underpinned our test of the efficacy of MSC exosomes in a porcine model of myocardial infarction (MI) when administered systemically by the convenient method of intravenous (IV) bolus injection. Results show that 7 days of IV exosomes results in clear reduction (30-40%) of infarct size measured at both 7 and 28 days post-MI, despite near identical release of hs Troponin T. Together with reduced infarct size, exosome treatment reduced transmurality and lessened wall thinning in the infarct zone. Exosome treated pigs showed relative preservation of LV function with significant amelioration of falls in fractional wall thickening compared with control. However, global measures of LV function were less protected by exosome treatment. It is possible that greater preservation of global LV function may have been attenuated by increased cardiac fibrosis, as T1 values showed significant increase in the exosome pigs compared to control particularly in the infarct related segments. Taken together, these results show clear effects of IV exosomes administered over 7 days to reduce infarct size with relatively preserved cardiac function compared to control treated infarct pigs.

摘要

间充质干细胞(MSCs)通过其分泌组发挥心脏保护和修复作用,其中的活性成分被确定为外泌体,这一观察结果支持了我们在猪心肌梗死(MI)模型中通过方便的静脉推注法全身给药来测试MSC外泌体疗效的研究。结果表明,静脉注射外泌体7天可使心肌梗死后7天和28天测量的梗死面积明显减小(30%-40%),尽管高敏肌钙蛋白T的释放量几乎相同。除了梗死面积减小外,外泌体治疗还降低了透壁性,并减轻了梗死区域的心肌壁变薄。与对照组相比,接受外泌体治疗的猪左心室功能相对得以保留,室壁增厚分数下降得到显著改善。然而,外泌体治疗对左心室功能的整体指标保护作用较小。与对照组相比,外泌体治疗组猪的T1值显著升高,尤其是在梗死相关节段,这可能是由于心脏纤维化增加,导致左心室整体功能的更大程度保留受到了削弱。综上所述,这些结果表明,与对照组相比,连续7天静脉注射外泌体可明显减小梗死面积,并相对保留心脏功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/52f99fec9fef/fcvm-07-601990-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/b48c1211a8ec/fcvm-07-601990-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/f79470814c4f/fcvm-07-601990-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/defd286c4f84/fcvm-07-601990-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/a4d769ad4604/fcvm-07-601990-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/79f690d8f753/fcvm-07-601990-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/89991e593f0a/fcvm-07-601990-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/52f99fec9fef/fcvm-07-601990-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/b48c1211a8ec/fcvm-07-601990-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/f79470814c4f/fcvm-07-601990-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/defd286c4f84/fcvm-07-601990-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/a4d769ad4604/fcvm-07-601990-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/79f690d8f753/fcvm-07-601990-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/89991e593f0a/fcvm-07-601990-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/7701257/52f99fec9fef/fcvm-07-601990-g0007.jpg

相似文献

1
Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine Model.全身间充质干细胞来源的外泌体可减小心肌梗死面积:猪模型的MRI特征分析
Front Cardiovasc Med. 2020 Nov 16;7:601990. doi: 10.3389/fcvm.2020.601990. eCollection 2020.
2
MSC exosome-mediated cardioprotection in ischemic mouse heart comparative proteomics of infarct and peri-infarct areas.MSC 外泌体介导的缺血性小鼠心脏保护作用:梗死区和梗死周边区的比较蛋白质组学研究。
Mol Cell Biochem. 2021 Apr;476(4):1691-1704. doi: 10.1007/s11010-020-04029-6. Epub 2021 Jan 10.
3
Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction.静脉注射同种异体脐带源多能间充质基质细胞可减少猪急性心肌梗死模型的梗死面积并改善心功能。
Stem Cell Res Ther. 2018 May 11;9(1):129. doi: 10.1186/s13287-018-0888-z.
4
Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model.富含 MSC 衍生细胞外囊泡的去细胞心脏支架可限制心室重构,并在心肌梗死猪模型中发挥局部和全身免疫调节作用。
Theranostics. 2022 Jun 6;12(10):4656-4670. doi: 10.7150/thno.72289. eCollection 2022.
5
Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction.在无免疫抑制情况下,心肌内注射同种异体骨髓间充质干细胞可在猪心肌梗死模型中保留心脏功能。
J Cardiovasc Pharmacol Ther. 2005 Dec;10(4):225-33. doi: 10.1177/107424840501000403.
6
Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair.过表达巨噬细胞移动抑制因子的间充质干细胞来源的外泌体可增强心肌修复。
J Cell Physiol. 2020 Nov;235(11):8010-8022. doi: 10.1002/jcp.29456. Epub 2020 Jan 20.
7
Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment.白细胞介素-10 缺乏通过整合素连接激酶富集改变内皮祖细胞衍生的外泌体对心肌修复的修复作用。
Circ Res. 2020 Jan 31;126(3):315-329. doi: 10.1161/CIRCRESAHA.119.315829. Epub 2019 Dec 9.
8
Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.猪自体两种骨髓干细胞移植改善左心室重构的机制
Chin Med J (Engl). 2008 Dec 5;121(23):2403-9.
9
Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence.血红素通过改善心肌细胞衰老增强间充质干细胞衍生的外泌体对梗死的心脏保护作用。
J Nanobiotechnology. 2021 Oct 21;19(1):332. doi: 10.1186/s12951-021-01077-y.
10
Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.携带有 QHREDGS 的自组装多肽作为心肌梗死后间充质干细胞移植的新型递送系统。
FASEB J. 2019 Jul;33(7):8306-8320. doi: 10.1096/fj.201801768RR. Epub 2019 Apr 10.

引用本文的文献

1
The Therapeutic Potential of Garlic-Derived Organic Polysulfides for Ischemia-Reperfusion Injury.大蒜衍生有机多硫化物对缺血再灌注损伤的治疗潜力
Int J Mol Sci. 2025 Aug 26;26(17):8257. doi: 10.3390/ijms26178257.
2
Intranasal administration of stem cell derivatives for the treatment of AD animal models: a systematic review and meta-analysis.经鼻给药干细胞衍生物治疗AD动物模型:一项系统评价和荟萃分析。
Stem Cell Res Ther. 2025 Jul 28;16(1):409. doi: 10.1186/s13287-025-04555-4.
3
Beneficial and challenges of exosome application in ischemic heart disease.

本文引用的文献

1
Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications.定义用于治疗应用的间充质基质细胞(MSC)衍生的小细胞外囊泡。
J Extracell Vesicles. 2019 Apr 29;8(1):1609206. doi: 10.1080/20013078.2019.1609206. eCollection 2019.
2
Bone marrow mesenchymal stem cells-derived conditioned medium protects cardiomyocytes from hypoxia/reoxygenation-induced injury through Notch2/mTOR/autophagy signaling.骨髓间充质干细胞条件培养液通过 Notch2/mTOR/自噬信号通路保护心肌细胞免受缺氧/复氧诱导的损伤。
J Cell Physiol. 2019 Aug;234(10):18906-18916. doi: 10.1002/jcp.28530. Epub 2019 Apr 5.
3
外泌体在缺血性心脏病中的应用的益处与挑战
Stem Cell Res Ther. 2025 May 19;16(1):247. doi: 10.1186/s13287-025-04363-w.
4
Diagnostic and prognostic roles of endothelial- and platelet-derived extracellular vesicles in cardiovascular diseases.内皮细胞和血小板衍生的细胞外囊泡在心血管疾病中的诊断和预后作用。
J Transl Med. 2025 May 16;23(1):553. doi: 10.1186/s12967-025-06522-2.
5
Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?心力衰竭治疗的现状:间充质干细胞及其外泌体是未来的治疗方法吗?
Front Cardiovasc Med. 2025 Apr 28;12:1518036. doi: 10.3389/fcvm.2025.1518036. eCollection 2025.
6
Cardiac rehabilitation in porcine models: Advances in therapeutic strategies for ischemic heart disease.猪模型中的心脏康复:缺血性心脏病治疗策略的进展
Zool Res. 2025 May 18;46(3):576-607. doi: 10.24272/j.issn.2095-8137.2024.387.
7
Exosomes in Systemic Autoimmune Diseases: Recent Advances in Diagnostic Biomarkers and Therapeutic Applications.系统性自身免疫性疾病中的外泌体:诊断生物标志物和治疗应用的最新进展
Int J Nanomedicine. 2025 Apr 21;20:5137-5160. doi: 10.2147/IJN.S506221. eCollection 2025.
8
Bibliometrics of trends in global research on the roles of stem cells in myocardial fibrosis therapy.全球干细胞在心肌纤维化治疗中作用的研究趋势的文献计量学
World J Stem Cells. 2024 Dec 26;16(12):1086-1105. doi: 10.4252/wjsc.v16.i12.1086.
9
Adult cardiomyocytes-derived EVs for the treatment of cardiac fibrosis.成体心肌细胞衍生的细胞外囊泡治疗心肌纤维化。
J Extracell Vesicles. 2024 Jul;13(7):e12461. doi: 10.1002/jev2.12461.
10
Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions.人类衰老与年龄相关疾病:从潜在机制到促长寿干预措施。
Aging Dis. 2024 Jun 14. doi: 10.14336/AD.2024.0280.
Back to square one.
回到原点。
Eur Heart J. 2019 Apr 1;40(13):1031-1033. doi: 10.1093/eurheartj/ehz094.
4
Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit.同种异体人心肌干细胞/祖细胞分泌的细胞外囊泡作为其治疗益处的一部分。
Stem Cells Transl Med. 2019 Sep;8(9):911-924. doi: 10.1002/sctm.18-0256. Epub 2019 Mar 28.
5
MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis.MSC 外泌体通过减轻炎症和恢复基质内稳态来缓解颞下颌关节骨关节炎。
Biomaterials. 2019 Apr;200:35-47. doi: 10.1016/j.biomaterials.2019.02.006. Epub 2019 Feb 8.
6
Human Mesenchymal Stem Cell-derived Exosomes Reduce Ischemia/Reperfusion Injury by the Inhibitions of Apoptosis and Autophagy.人骨髓间充质干细胞来源的外泌体通过抑制细胞凋亡和自噬来减少缺血/再灌注损伤。
Curr Pharm Des. 2018;24(44):5334-5341. doi: 10.2174/1381612825666190119130441.
7
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.细胞外囊泡研究的最低限度信息2018(MISEV2018):国际细胞外囊泡协会的立场声明及MISEV2014指南的更新
J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.
8
Cardiac Progenitor Cell-Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation.心脏祖细胞衍生的细胞外囊泡可减少梗死面积,并与心血管细胞增殖增加相关。
J Cardiovasc Transl Res. 2019 Feb;12(1):5-17. doi: 10.1007/s12265-018-9842-9. Epub 2018 Nov 19.
9
Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium.心肌缺血模型中,心脏间充质干细胞来源的外泌体移植促进修复。
J Cardiovasc Transl Res. 2018 Oct;11(5):420-428. doi: 10.1007/s12265-018-9822-0. Epub 2018 Sep 19.
10
Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway.间充质基质细胞外泌体通过抗原呈递细胞介导的途径增强调节性 T 细胞的产生。
Cytotherapy. 2018 May;20(5):687-696. doi: 10.1016/j.jcyt.2018.02.372. Epub 2018 Apr 2.